文献速递妇科

早期宫颈癌的实践模式与90天治疗相关发病率

Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
PubMed 文献 · Gynecol Oncol · 2022-07-29

这项回顾性多机构研究评估了LACC试验发表前后早期宫颈癌患者的90天手术相关结局。LACC试验发表后,微创根治性子宫切除术从64.9%降至30.4%(p<0.001),但90天总体并发症(18.9% vs 16.6%,p=0.795)和严重并发症(6.5% vs 5.1%,p=0.297)在两个时期无显著差异。

要点

  • LACC试验发表后,微创根治性子宫切除术从64.9%降至30.4%(p<0.001)。
  • 90天总体并发症在LACC试验发表前后分别为18.9%和16.6%(p=0.795)。
  • 90天严重并发症(3级或更差)在LACC试验发表前后分别为6.5%和5.1%(p=0.297)。

核心结论

  • 在转诊中心,从微创根治性子宫切除术转为开放根治性子宫切除术不影响90天手术相关发病率。

研究设计与样本

  • 这是一项回顾性、多机构研究,评估早期宫颈癌患者在LACC试验结果发表前(时期I:2016年1月1日至2018年6月1日)和发表后(时期II:2019年1月1日至2021年6月1日)接受治疗的90天手术相关结局。
  • 共评估1295例患者的病历,其中581例(44.9%)在LACC试验发表前,714例(55.1%)在发表后。

主要发现

  • LACC试验发表后,接受微创根治性子宫切除术的患者数量从64.9%降至30.4%(p<0.001)。
  • 90天并发症在时期I和时期II分别发生于110例(18.9%)和119例(16.6%)患者(p=0.795)。
  • 严重(3级或更差)并发症数量在两个时期之间无差异(38例(6.5%)vs 37例(5.1%);p=0.297)。
  • 分别评估IA期(p=0.471)、IB1期(p=0.929)和IB2期(p=0.074)时,两个时期的总体和严重90天并发症保持一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the impact of the Laparoscopic Approach to Cervical Cancer (LACC) Trial on patterns of care and surgery-related morbidity in early-stage cervical cancer. METHODS: This is a retrospective, a multi-institutional study evaluating 90-day surgery-related outcomes of patients undergoing treatment for early-stage cervical cancer before (period I: 01/01/2016-06/01/2018) and after (period II: 01/01/2019-06/01/2021) the publication of the results of the LACC trial. RESULTS: Charts of 1295 patients were evaluated: 581 (44.9%) and 714 (55.1%) before and after the publication of the LACC trial, respectively. After the publication of the LACC trial, the number of patients treated with minimally invasive radical hysterectomy decreased from 64.9% to 30.4% (p < 0.001). Overall, 90-day complications occurred in 110 (18.9%) and 119 (16.6%) patients in the period I and period II, respectively (p = 0.795). Similarly, the number of severe (grade 3 or worse) complications did not differ between the two periods (38 (6.5%) vs. 37 (5.1%); p = 0.297). Overall and severe 90-day complications were consistent between periods even evaluating stage IA (p = 0.471), IB1 (p = 0.929), and IB2 (p = 0.074), separately. CONCLUSIONS: The present investigation highlighted that in referral centers the shift from minimally invasive to open radical hysterectomy does not influence 90-day surgery-related morbidity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bogani G, Donato VD, Scambia G, et al. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer. Gynecol Oncol. 2022. PMID: 35909005. doi:10.1016/j.ygyno.2022.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。